Mackenzie Bean on Muck Rack

Mackenzie Bean

Verified
Chicago
As seen in: Becker's Hospital Review, health.einnews.com, Becker's ASC Review, Becker's Spine Review, Our Community Now, Becker's Payer Issues, Becker's Behavioral Health, Becker's Dental Review, Becker's Physician Leadership, City-County Observer, Becker's Oncology and
AVP and Managing Editor for Becker's Hospital Review, covering news on patient safety, clinical quality and infection control.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mackenzie

Contact Mackenzie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

HCA chief clinical officer to step down

|
By Mackenzie Bean Verified
| Becker's Hospital Review Verified
Michael Cuffe, MD, executive vice president and chief clinical officer of Nashville-based HCA Healthcare, will step down from his role effective Aug. 31, according to a June 18 SEC filing. Dr. Cuffe will remain with the company in a transitional role through February 2027. He joined HCA in 2011 as president and CEO of physician services, a role he held for roughly a decade.
Open in Who Shared Issue with article?

States ranked by Medicaid prescription drug spend

|
By Mackenzie Bean Verified
| Becker's Hospital Review Verified
California, New York and Ohio led all states in gross Medicaid prescription drug spending in fiscal year 2024, accounting for more than a quarter of national spend, according to a KFF analysis of federal data. The figures reflect gross spending before manufacturer rebates on covered outpatient drugs under the Medicaid Drug Rebate Program, drawn from CMS state drug utilization data and CMS-64 financial management reports in April.
Open in Who Shared Issue with article?

FDA approves 1st single-dose generic flu drug

|
By Mackenzie Bean Verified
| Becker's Hospital Review Verified
The FDA approved the first generic version of Xofluza (baloxavir marboxil) on June 17, clearing Norwich Pharmaceuticals’ single-dose influenza tablet ahead of the 2026–27 flu season. Generic baloxavir marboxil is approved to treat acute uncomplicated influenza in patients 5 and older who have been symptomatic for no more than 48 hours. It’s also approved for post-exposure prophylaxis for the same age group.
Open in Who Shared Issue with article?
See all 6,458 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified